Molecular Breast Imaging

Molecular breast imaging (MBI) is a method for detecting breast cancer. The technique is also known as a Miraluma (pronounced mee-ra-LOO-ma) test, sestamibi (pronounced ses-ta-MI-bee), scintimammography, or breast specific gamma imaging.
MBI uses a radioactive tracer that “lights up” any areas of cancer inside the breast. This tracer is injected into the body through a vein in the arm. Breast cancer cells tend to take up the radioactive substance much more than normal cells do. A special camera called a nuclear medicine scanner then scans the breast, looking for any areas where the radioactive substance is concentrated.

To know more about #Molecular_Breast_Imaging, Join us with #Breast_Cancer2018_Conference on #October15_16,2018 @Rome, Italy

Follow the link for more details-https://breastcancer.pulsusconference.com/
 drop your query at- breastcancer@pulsusmeet.org / breastcancer@pulsusevents.org